Aytu Biopharma (AYTU) Cash from Financing Activities (2010 - 2026)
Aytu Biopharma's Cash from Financing Activities was -$4.8 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $12.99 million a year earlier.
Powered by 
Analysis
Aytu Biopharma (AYTU) Cash from Financing Activities (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Cash from Financing Activities at Aytu Biopharma came in at -$7.9 million.
- In earlier fiscal years, Cash from Financing Activities was $15.44 million in FY2025, -$1.26 million in FY2024, $8.87 million in FY2023 (+479.8%) and $1.53 million in FY2022 (-95.0%).
- Quarterly Cash from Financing Activities has moved between -$6.26 million (fiscal Q2 2026) and $13.56 million (fiscal Q1 2023) over five years.
- Per Business Quant data, AYTU's Cash from Financing Activities in the three fiscal quarters before Q4 2026 was $872,000 (Q3 2026), -$6.26 million (Q2 2026) and $2.3 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | -4.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.80 Mn |
| Mar 31, 2026 | 872,000.00 |
| Dec 31, 2025 | -6.26 Mn |
| Sep 30, 2025 | 2.30 Mn |
| Jun 30, 2025 | 12.99 Mn |
| Mar 31, 2025 | 4.30 Mn |
| Dec 31, 2024 | -2.76 Mn |
| Sep 30, 2024 | 911,000.00 |
| Jun 30, 2024 | 1.07 Mn |
| Mar 31, 2024 | 530,000.00 |
| Dec 31, 2023 | -126,000.00 |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | -5.40 Mn |
| Mar 31, 2023 | 2.58 Mn |
| Dec 31, 2022 | -1.87 Mn |
| Sep 30, 2022 | 13.56 Mn |
| Jun 30, 2022 | -1.12 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 6.59 Mn |
| Sep 30, 2021 | -5.46 Mn |
API Access
Aytu Biopharma Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();